NTRP vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

NTRP

50.1
AI Score
VS
NTRP Wins

CBIO

46.3
AI Score

Investment Advisor Scores

NTRP

50score
Recommendation
HOLD

CBIO

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NTRP CBIO Winner
Revenue 2.00M 1.04M NTRP
Net Income -6.85M -48.12M NTRP
Net Margin -342.7% -4631.4% NTRP
Operating Income -6.23M -51.09M NTRP
ROE -142.9% -29.5% CBIO
ROA -53.5% -26.3% CBIO
Total Assets 12.81M 182.76M CBIO
Cash 1.15M 171.59M CBIO
Current Ratio 0.49 9.66 CBIO

Relative Price Performance (Last 90 Days)

NTRP 1M: -43.7% · 3M: -33.1% CBIO 1M: +14.3% · 3M: -11.3%

Current Technical Phase

NTRP

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 34

RSI (14): 34.4 · Price: $1.03

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.6 · Price: $14.76

Fundamentals Snapshot

Metric NTRP CBIO
Market Cap — —
Forward P/E -2.5 -5.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.3% 0.0%
Gross Margin 0.2% 1.0%
Operating Margin -6.1% -14.3%
EPS -1.27 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NTRP is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.